跳至主要内容
临床试验/NCT03218189
NCT03218189已完成不适用

Differences Between Essential Medicines Lists in 135 Countries and the World Health Organization's Model List of Essential Medicines

Unity Health Toronto1 个研究点 分布在 1 个国家目标入组 137 人开始时间: 2017年7月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
137
试验地点
1
主要终点
Total number of differences between the WHO model list of essential medicines and the essential medicines list in each country

研究概览

简要总结

The World Health Organization (WHO) has developed a model list of more than 400 medicines and recommends that each country adapt the list to its own circumstances. More than 100 countries have developed essential medicines lists.

Some countries have essential medicines lists that are very similar to the WHO's model list and other countries have lists that are very different from the WHO's model list. Differences between the WHO list and country lists could be explained by features of the country including population demographics, disease prevalence, Gross Domestic Product (GDP), and healthcare system organization. Other factors such as the influence of particular individuals or organizations may also explain differences between countries.

The purpose of this project is to compare the essential medicines lists developed by countries with the WHO's model list and to identify attributes of countries that are associated with differences from the WHO list. Predictors such as region, population, life expectancy, infant mortality rate, GDP per capita, health expenditure per capita, inequality, and the corruption perception index will be considered.

详细描述

Statistical analysis plan for objective 3 (relationship between the total number of differences and country features)

Plots will be generated to show the relationships between variables. Correlation coefficients will be calculated where appropriate. Two separate multivariate models will be fit to the data for outcomes 2a and 2b [continuous, between 1 and 500]. A similar model will be fit the total number of differences. The analytical method will be determined by the data and may be liner regression.

Predictors:

Region-Categorical (6)

Population-Continuous

研究设计

研究类型
Observational
观察模型
Ecologic Or Community
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • Countries that have an essential medicines list, and Canada

排除标准

  • countries that do not have an essential medicines list that is available online

结局指标

主要结局

Total number of differences between the WHO model list of essential medicines and the essential medicines list in each country

时间窗: 1 year

The total number of differences between the WHO model list of essential medicines and the essential medicines list in each country is comprised of: 1. number of WHO model list medicines not on country list including the number of substitutions within class (i.e. a medicine on WHO list not on country's list but a similar agent in the same class is on the country's list); and the 2. number of medicines on the country list but not on the WHO model list.

次要结局

  • Medications that are on the WHO list but not on the country list(1 year)
  • Medications that are on the country list but not on the WHO list(1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验